MRI Interventions, Inc. Announces 2015 Fourth Quarter and Full Year Results
Mar 23, 2016 20:05 pm UTC| Business
IRVINE, Calif., March 23, 2016 -- MRI Interventions, Inc. (OTCQB:MRIC) today announced financial results for the fourth quarter and full year ended December 31, 2015. Quarter Ended December 31, 2015 Revenues were...
Sagent Pharmaceuticals Names Sean Brynjelsen Executive Vice President, Business Development
Mar 23, 2016 20:05 pm UTC| Business
SCHAUMBURG, Ill., March 23, 2016 -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) a leading provider of affordable pharmaceuticals to the hospital market, announced the hiring of Sean Brynjelsen as Executive Vice...
Nevada Zinc Increases Financing by 33% to $2.0 Million
Mar 23, 2016 20:02 pm UTC| Business
TORONTO, March 23, 2016 -- Nevada Zinc Corporation (the “Corporation”) (TSX-V:NZN) is pleased to announce increased investor demand in connection with its previously announced $1,500,000 private placement (the...
Sportsman’s Warehouse announces two additional new stores scheduled to open in 2016
Mar 23, 2016 20:02 pm UTC| Business
MIDVALE, Utah, March 23, 2016 -- Sportsman’s Warehouse (Nasdaq:SPWH) is expanding its operations to include new retail locations in Avondale, Arizona, and Fairfield, California. The Avondale store will be the seventh...
Sportsman's Warehouse Holdings, Inc. Announces Fourth Quarter and Full Year 2015 Financial Results
Mar 23, 2016 20:01 pm UTC| Business
MIDVALE, Utah, March 23, 2016 -- Sportsman's Warehouse Holdings, Inc. ("Sportsman's" or the “Company”) (Nasdaq:SPWH) today announced financial results for the thirteen and fifty-two weeks ended January 30, 2016. For the...
Vitae Pharmaceuticals Proposes Public Offering of Common Stock
Mar 23, 2016 20:01 pm UTC| Business
FORT WASHINGTON, Pa., March 23, 2016 -- Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE) (Vitae), a clinical-stage biotechnology company, today announced that it intends to offer and sell shares of its common stock in an...
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2015 Operating and Financial Results
Mar 23, 2016 20:01 pm UTC| Business
MALVERN, Pa., March 23, 2016 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, today announced financial results for the fourth quarter and year ended December 31, 2015 and...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight